The Wiki
The Wiki contains all the articles on the web site. The articles are put into categories and 'tagged' for easier searching.
Seeing how the Hepatitis C virus builds ion channels could help researchers find new drugs to fight the disease The Hepatitis C virus’s p7 ion channel is crucial to the assembly and release of infectious HCV viral particles. That makes it a tempting target for drugs to fight the disease. Credit: James Chou (Phys.org) —Viruses…
Unacceptable Behaviour with Alcohol-related liver disease patients: Report The National Confidential Enquiry Into Patient Outcome and Death (NCEPOD) has carried out a review and has uncovered sad picture of activities taking place in health service. The report unveiled that hospitals have not been treating alcohol-related liver disease patients. There are a number of things that…
Soon, implantable sensor can detect early stages of organ transplant rejection Washington: The Ohio State University is working on a new technology, which will pave the way for low-cost electronic devices that work in direct contact with living tissue inside the body. The first planned use of the technology is a sensor that…
Rates of Hepatitis C double in P.E.I.Deputy chief health officer Dr. Lamont Sweet says hepatitis C numbers are rising in Prince Edward Island. Teresa Wright Dr. Lamont Sweet says rising number of cases will impact Prince Edward Island’s health system in coming years Topics : P.E.I. , Mount Herbert A growing number of Islanders…
An apple a day keeps the doctor away. This age old saying has never rang with greater promise and authority than it does today. As in the modern era, doctors bring with them a battery of tests, drugs , and interventions , all of which carry unintended, adverse health risks that often outweigh their purported…
Gilead Anti-Hep-C Treatment on the FDA Fast Track By Rich Smith | More ArticlesJune 8, 2013 | Comments (1) Gilead Sciences (NASDAQ: GILD ) has received FDA priority review status for its New Drug Application for sofosbuvir, the company announced Friday. Sofosbuvir is a once-daily oral nucleotide analogue inhibitor for the treatment of chronic hepatitis…
Vitamin Bashing or Bad Science? Posted on: Wednesday, June 13th 2012 at 9:30 am Written By: Orthomolecular News Service Vitamin Bashing or Bad Science? (Orthomolecular Medicine News Service, June 11, 2012) by Steve Hickey, PhD, Andrew W. Saul, PhD, and Robert G. Smith, PhD (OMNS June 11, 2012) There is a global tendency to popularize…
How antioxidants work Oxygen is necessary for life, but on the other hand it inevitably generates reactive molecules throughout all the tissues of the body. These free radicals are dangerous for any cell because they can damage essential molecules such as DNA and the enzymes necessary for proper function of the cell. Antioxidants capture these…
Who Wrote Alcoholic Cirrhosis as a Syndrome? When I found a paper on the Internet, Alcoholic Cirrhosis as a Syndrome it was that magic wand I had been looking for. I read it, digested it and applied the knowledge I gained from it. Had I not done so I have no doubt I would have…
We need to reclaim sport from the drinks industry Opinion: The industry is using its influence to prevent reform As specialists in liver disease, my colleagues and I have seen at first hand the results of the increase in alcohol consumption of recent years. As a nation, we are now drinking twice as much as…